Addition of plerixafor in poorly mobilized allogeneic stem cell donors
Journal of Clinical Apheresis · 2022-08 · 37 (4) · 388-394
DOI: 10.1002/jca.21992 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Apheresis, online erschienen am 28.05.2022. Verfasst von Lefan Zhuang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Transfusion Medicine, Department of Pathology, City of Hope National Medical Center, Duarte, California, USA. Hauptthemen laut MEDLINE: Cyclams, Hematopoietic Stem Cell Transplantation, Heterocyclic Compounds, Peripheral Blood Stem Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Peripheral blood stem cells (PBSCs) are the predominant graft source for adult allogeneic hematopoietic stem cell transplantation (HSCT). In poorly mobilized autologous donors, plerixafor improves collection outcomes. We examine plerixafor use in allogeneic donors who mobilize poorly with granulocyte colony‐stimulating factor (G‐CSF) in those who are healthy and those with pre‐existing medical conditions, and determine the optimal threshold to add plerixafor. Study Design/Methods We retrospectively examined all allogeneic PBSC collections from January 2013 to October 2020 at our center. Donors received G‐CSF 10 mcg/kg daily for 4 days before undergoing apheresis collection on day 5. Plerixafor was added based on poor CD34+ cell collection yield after the first or second collection day.
Results
Of the 1008 allogeneic donors, 41 (4.1%) received one dose of plerixafor in addition to G‐CSF due to poor collection yield. After starting plerixafor there was a 0.75‐ to 7.74‐fold (median 2.94) increase in CD34+ yield from the previous day. No donors with G‐CSF‐only mobilization who collected
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Transfusion Medicine, Department of Pathology, City of Hope National Medical Center, Duarte, California, USA.
Zitieren
APA
Zhuang, L., Lauro, D., Wang, S., & Yuan, S. (2022). Addition of plerixafor in poorly mobilized allogeneic stem cell donors. Journal of Clinical Apheresis, 37(4), 388-394. https://doi.org/10.1002/jca.21992
Vancouver
Zhuang L, Lauro D, Wang S, Yuan S. Addition of plerixafor in poorly mobilized allogeneic stem cell donors. Journal of Clinical Apheresis. 2022;37(4):388-394. doi:10.1002/jca.21992
BibTeX
@article{Zhuang2022,
author = {Zhuang, Lefan and Lauro, Deisen and Wang, Shirong and Yuan, Shan},
title = {Addition of plerixafor in poorly mobilized allogeneic stem cell donors},
journal = {Journal of Clinical Apheresis},
year = {2022},
volume = {37},
number = {4},
pages = {388--394},
doi = {10.1002/jca.21992}
}
EUVIMED